详情页 - 河北医科大学第四医院机构库

资源类型：

文章类型：

作者：

Zuo, Jin[1] * ; Wu, Lingying[1] ; Li, Xiaofan[2] ; Feng, Mei[3] ; Li, Guiling[4] ; Yin, Rutie[5] ; Li, Xiumin[6] ; Kang, Shan[7]

; Sun, Hongmei[8] ; Wei, Shuqing[9] ; Zhang, Yunyan[10] ; Wang, Yili[11] ; Liu, Hu[12] ; Wang, Wei[13] ; Sun, Li[14] ; Zhu, Zhitu[15] ; Lin, Daren[16] ; Jiang, Kui[17] ; Xiang, Silong[18] ; Niu, Miao[19] ;

机构： [1]Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Natl Clin Res Ctr Canc, Canc Hosp, Beijing, Peoples R China [2]Peking Univ Canc Hosp & Inst, Beijing, Peoples R China [3]Fujian Med Univ, Oncol Sch, Fujian Canc Hosp, Fuzhou, Peoples R China [4]Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Wuhan, Peoples R China [5]Sichuan Univ, Minist Educ, Key Lab Birth Defects & Related Dis Women & Child, West China Univ Hosp 2, Chengdu, Peoples R China [6]Linyi Canc Hosp, Dept Gynecol Oncol, Linyi, Shandong, Peoples R China [7]Hebei Med Univ, Hosp 4, Shijiazhuang, Hebei, Peoples R China [8]Hebei Tumor Hosp, Shijiazhuang, Hebei, Peoples R China [9]Jiamusi Canc & TB Hosp, Jiamusi City, Heilongjiang, Peoples R China [10]Shanxi Med Univ, Shanxi Prov Canc Hosp, Shanxi Hosp, Canc Hosp,Acad Med Sci, Taiyuan, Peoples R China [11]Harbin Med Univ, Canc Hosp, Harbin, Peoples R China [12]Gannan Med Univ, Affiliated Hosp 1, Dept Oncol, Ganzhou, Peoples R China [13]Univ Sci & Technol China, Affiliated Hosp, Hefei, Peoples R China [14]Shanxi Med Univ, Dept Obstet & Gynecol, Hosp 2, Taiyuan, Peoples R China [15]Qingdao Univ, Coll Med, Affiliated Hosp 2, Qingdao Cent Hosp,Dept Gynecol Oncol, Qingdao, Peoples R China [16]Liaoning Med Univ, Affiliated Hosp 1, Jinzhou, Peoples R China [17]Jiangmen Cent Hosp, Jiangmen, Peoples R China [18]Dalian Med Univ, Affiliated Hosp 2, Dalian, Peoples R China [19]CSPC Zhongqi Pharmaceut Technol Co Ltd, Beijing, Peoples R China

出处：

ISSN：

基金：

语种：

被引次数：

WOS：

中科院分区：

出版当年[2025]版：

大类 | 1 区

医学

小类 | 1 区肿瘤学

最新[2025]版：

大类 | 1 区

医学

小类 | 1 区肿瘤学

JCR分区：

出版当年[2024]版：

无

最新[2023]版：

Q1 ONCOLOGY

第一作者：

第一作者机构： [1]Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Natl Clin Res Ctr Canc, Canc Hosp, Beijing, Peoples R China

推荐引用方式(GB/T 7714)：

APA：

MLA：

Efficacy and safety of enlonstobart (SG001), a PD-1 inhibitor in patients with PD-L1 positive recurrent/metastatic cervical cancer: A multicenter, single-arm, open-label, phase II study

文献详情